IL120979A0 - Glycosylated TNF - Google Patents

Glycosylated TNF

Info

Publication number
IL120979A0
IL120979A0 IL12097997A IL12097997A IL120979A0 IL 120979 A0 IL120979 A0 IL 120979A0 IL 12097997 A IL12097997 A IL 12097997A IL 12097997 A IL12097997 A IL 12097997A IL 120979 A0 IL120979 A0 IL 120979A0
Authority
IL
Israel
Prior art keywords
glycosylated tnf
glycosylated
tnf
Prior art date
Application number
IL12097997A
Original Assignee
Interpharm Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Interpharm Lab Ltd filed Critical Interpharm Lab Ltd
Priority to IL12097997A priority Critical patent/IL120979A0/en
Publication of IL120979A0 publication Critical patent/IL120979A0/en
Priority to AU75466/98A priority patent/AU746411B2/en
Priority to CA002289564A priority patent/CA2289564A1/en
Priority to IL13328398A priority patent/IL133283A0/en
Priority to EP98923041A priority patent/EP0985040A1/en
Priority to PCT/IL1998/000254 priority patent/WO1998055622A1/en
Priority to JP50199299A priority patent/JP2002502257A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/525—Tumour necrosis factor [TNF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
IL12097997A 1997-06-02 1997-06-02 Glycosylated TNF IL120979A0 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
IL12097997A IL120979A0 (en) 1997-06-02 1997-06-02 Glycosylated TNF
AU75466/98A AU746411B2 (en) 1997-06-02 1998-06-01 Preparation of glycosylated tumor necrosis factor
CA002289564A CA2289564A1 (en) 1997-06-02 1998-06-01 Preparation of glycosylated tumor necrosis factor
IL13328398A IL133283A0 (en) 1997-06-02 1998-06-01 Preparation of glycosylated tumor necrosis factor
EP98923041A EP0985040A1 (en) 1997-06-02 1998-06-01 Preparation of glycosylated tumor necrosis factor
PCT/IL1998/000254 WO1998055622A1 (en) 1997-06-02 1998-06-01 Preparation of glycosylated tumor necrosis factor
JP50199299A JP2002502257A (en) 1997-06-02 1998-06-01 Preparation of glycosylated tumor necrosis factor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL12097997A IL120979A0 (en) 1997-06-02 1997-06-02 Glycosylated TNF

Publications (1)

Publication Number Publication Date
IL120979A0 true IL120979A0 (en) 1997-11-20

Family

ID=11070212

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12097997A IL120979A0 (en) 1997-06-02 1997-06-02 Glycosylated TNF

Country Status (6)

Country Link
EP (1) EP0985040A1 (en)
JP (1) JP2002502257A (en)
AU (1) AU746411B2 (en)
CA (1) CA2289564A1 (en)
IL (1) IL120979A0 (en)
WO (1) WO1998055622A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6579522B1 (en) 2000-06-27 2003-06-17 Genvec, Inc. Replication deficient adenoviral TNF vector
US20030086903A1 (en) 2001-11-02 2003-05-08 Genvec, Inc. Therapeutic regimen for treating cancer
JP2008528006A (en) * 2005-01-28 2008-07-31 アポロ ライフ サイエンシズ リミテッド Molecule and its chimeric molecule

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR851626B (en) * 1984-07-05 1985-11-26 Genentech Inc
AU1346488A (en) * 1987-02-26 1988-09-26 Cetus Corporation Arginine-depleted human tumor necrosis factor
US5378603A (en) * 1987-03-30 1995-01-03 Board Of Regents, The University Of Texas System Method and composition for identifying substances which activate transcription of the LDL receptor gene

Also Published As

Publication number Publication date
AU746411B2 (en) 2002-05-02
EP0985040A1 (en) 2000-03-15
CA2289564A1 (en) 1998-12-10
AU7546698A (en) 1998-12-21
JP2002502257A (en) 2002-01-22
WO1998055622A1 (en) 1998-12-10

Similar Documents

Publication Publication Date Title
TW373796U (en) Keystoke structure
PL335973A1 (en) Connection
SG72879A1 (en) Chipcard-contacting unit
GB9715267D0 (en) Stethescope structure
GB9707849D0 (en) Structure
EP1001981A4 (en) Heregulin-like factor
IL120979A0 (en) Glycosylated TNF
GB9811074D0 (en) Connections
GB9706722D0 (en) Concrete-reinforcing structures
GB2321941B (en) Connection element
GB2328633B (en) Wheelbrace
GB9700014D0 (en) Interface
GB9701844D0 (en) Rakgard
TW334678U (en) Dovecote structure
TW446065U (en) Door-in-door structure
HU9700108V0 (en) Structure
TW323625U (en) Can structure
CA82746S (en) Handleset
GB9722697D0 (en) Experiment preparation unit
GB9713988D0 (en) Screw connection
TW332628U (en) Improved screw structure
GB9713185D0 (en) Response unit
TW334796U (en) Improved Hula-hoop structure
TW334786U (en) Improved bathbrush structure
TW333808U (en) Improved jardiniere structure